Brought to you by 
Hanmi grants Amneal exclusive US distribution rights to esomeprazole strontium
01 Mar 2013
Executive Summary
South Korean therapeutics developer Hanmi Pharmaceutical Co. Ltd. has licensed generics company Amneal Pharmaceuticals LLC exclusive rights to distribute its esomeprazole strontium delayed-release capsules in the US.
Deal Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
- Generic Drugs
Deal Status
- Final
Deal Type
-
Alliance
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Hanmi grants Amneal exclusive US distribution rights to esomeprazole strontium
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice